IL33 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), both recombinant IL-33 treated cells and IL-33 overexpressing cells exhibited increased cell growth and invasion both in in vitro and in vivo experiments by implanting these cells into nude mice 8.